Janney Capital Maintains Buy on Marker Therapeutics, Lowers Price Target to $10

Janney Capital maintains Marker Therapeutics (NASDAQ:MRKR) with a Buy and lowers the price target from $15 to $10.

Benzinga · 11/13/2019 11:59

Janney Capital maintains Marker Therapeutics (NASDAQ:MRKR) with a Buy and lowers the price target from $15 to $10.